223Ra

Open Access
¹⁷⁷Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior ²²³Ra (RALU Study)
Kambiz Rahbar, Markus Essler, Matthias Eiber, Christian la Fougère, Vikas Prasad, Wolfgang P. Fendler, Philipp Rassek, Ergela Hasa, Helmut Dittmann, Ralph A. Bundschuh, Kim M. Pabst, Milena Kurtinecz, Anja Schmall, Frank Verholen and Oliver Sartor

Journal of Nuclear Medicine December 1, 2023, 64 (12) 1925-1931; DOI: https://doi.org/10.2967/jnumed.123.266125
You have access
⁶⁸Ga-PSMA PET/CT for Response Evaluation of ²²³Ra Treatment in Metastatic Prostate Cancer
Anouk C. de Jong, Marcel Segbers, Sui Wai Ling, Laura H. Graven, Niven Mehra, Paul Hamberg, Tessa Brabander, Ronald de Wit and Astrid A.M. van der Veldt

Journal of Nuclear Medicine October 1, 2023, 64 (10) 1556-1562; DOI: https://doi.org/10.2967/jnumed.123.265489
Open Access
Pain Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ²²³Ra: PARABO, a Prospective, Noninterventional Study
Holger Palmedo, Hojjat Ahmadzadehfar, Susanne Eschmann, Andreas Niesen, Johann Schönberger, Vahé Barsegian, Knut Liepe, Felix M. Mottaghy, Rongjin Guan, Joerg Pinkert, Per Sandström and Ken Herrmann

Journal of Nuclear Medicine September 1, 2023, 64 (9) 1392-1398; DOI: https://doi.org/10.2967/jnumed.123.265557
Open Access
Safety and Survival Outcomes of ¹⁷⁷Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior ²²³Ra treatment: The RALU Study
Kambiz Rahbar, Markus Essler, Kim M. Pabst, Matthias Eiber, Christian la Fougère, Vikas Prasad, Philipp Rassek, Ergela Hasa, Helmut Dittmann, Ralph A. Bundschuh, Wolfgang P. Fendler, Milena Kurtinecz, Anja Schmall, Frank Verholen and Oliver Sartor

Journal of Nuclear Medicine April 1, 2023, 64 (4) 574-578; DOI: https://doi.org/10.2967/jnumed.122.264456
You have access
Combined Targeted Radiopharmaceutical Therapy and Immune Checkpoint Blockade: From Preclinical Advances to the Clinic
Michael C. Bellavia, Ravi B. Patel and Carolyn J. Anderson

Journal of Nuclear Medicine November 1, 2022, 63 (11) 1636-1641; DOI: https://doi.org/10.2967/jnumed.122.264373
You have access
²²³Ra Induces Transient Functional Bone Marrow Toxicity
Maria Parlani, Francesco Boccalatte, Anna Yeaton, Feng Wang, Jianhua Zhang, Iannis Aifantis and Eleonora Dondossola

Journal of Nuclear Medicine October 1, 2022, 63 (10) 1544-1550; DOI: https://doi.org/10.2967/jnumed.121.263310
You have access
Enhancing ²²³Ra Treatment Efficacy by Anti-β1 Integrin Targeting
Claudia Paindelli, Stefano Casarin, Feng Wang, Luis Diaz-Gomez, Jianhua Zhang, Antonios G. Mikos, Christopher J. Logothetis, Peter Friedl and Eleonora Dondossola

Journal of Nuclear Medicine July 1, 2022, 63 (7) 1039-1045; DOI: https://doi.org/10.2967/jnumed.121.262743
Open Access
¹⁷⁷Lu-Prostate-Specific Membrane Antigen Ligand After ²²³Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
Oliver Sartor, Christian la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer, Jörg Ellinger, Luke Nordquist, John Sylvester, Giovanni Paganelli, Avivit Peer, Martin Bögemann, Jeffrey Meltzer, Per Sandström, Frank Verholen and Daniel Y. Song

Journal of Nuclear Medicine March 1, 2022, 63 (3) 410-414; DOI: https://doi.org/10.2967/jnumed.121.262240
Open Access
Improved ²²³Ra Therapy with Combination Epithelial Sodium Channel Blockade
Diane S. Abou, Amanda Fears, Lucy Summer, Mark Longtine, Nadia Benabdallah, Ryan C. Riddle, David Ulmert, Jeff M. Michalski, Richard L. Wahl, Denise Chesner, Michele Doucet, Nicholas C. Zachos, Brian W. Simons and Daniel L.J. Thorek

Journal of Nuclear Medicine December 1, 2021, 62 (12) 1751-1758; DOI: https://doi.org/10.2967/jnumed.121.261977
You have access
The Prognostic Value of Quantitative Bone SPECT/CT Before ²²³Ra Treatment in Metastatic Castration-Resistant Prostate Cancer
Helmut Dittmann, Sabine Kaltenbach, Matthias Weissinger, Francesco Fiz, Peter Martus, Maren Pritzkow, Juergen Kupferschlaeger and Christian la Fougère

Journal of Nuclear Medicine January 1, 2021, 62 (1) 48-54; DOI: https://doi.org/10.2967/jnumed.119.240408

Main menu

User menu

Search

223Ra

Pages